| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/31/2006 | US20060195915 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture |
| 08/31/2006 | US20060194952 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/31/2006 | US20060194951 Polynucleotides encoding interferon gamma polypeptides |
| 08/31/2006 | US20060194950 separating antibodies from proteases; provide a mutated immunoglobulin-binding protein ligand that exhibits an improved stability at increased pH-values, and accordingly an improved tolerance to cleaning under alkaline conditions |
| 08/31/2006 | US20060194949 Structure of the farnesoid x receptor ligand binding domain and methods of use therefor |
| 08/31/2006 | US20060194940 Water-soluble polymer alkanals |
| 08/31/2006 | US20060194753 Agent for treating leishmania infections |
| 08/31/2006 | US20060194751 Streptococcus pyogenes antigens |
| 08/31/2006 | US20060194739 Nociceptin-based analgesics |
| 08/31/2006 | US20060194737 Hepta-, octa-and nonapeptides having antiangiogenic activity |
| 08/31/2006 | US20060194736 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 08/31/2006 | US20060194735 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 08/31/2006 | US20060194732 Lipid-free powder form of surfactant protein A with a carrier; microbiocides; antiinflammatory and bronchodilator agents |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194730 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 08/31/2006 | US20060194727 Prevention and reduction of blood loss |
| 08/31/2006 | US20060194720 Human glucagon-like peptide-1 (GLP-1) derivatives absorbed highly via a mucous membrane in the oral cavity, lung, nose or intestines; for therapy of non-insulin dependent diabetes muellitus, insulin dependent diabetes mellitus and/or obesity |
| 08/31/2006 | US20060194719 Stabilized exendin-4 compounds |
| 08/31/2006 | US20060194715 Proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/31/2006 | US20060194340 Also, utilization of mass spectrometry (e.g., Surface Enhanced Laser Desorption Ionization, Maldi Qq TOF, MS/MS, TOF TOF, ESI-Q-TOF or ION-TRAP) to elucidate particular indicative or predictive biopolymer markers |
| 08/31/2006 | US20060194339 Isolated biopolymer marker peptide; using mass spectrometry to determine markers predictive of insulin resistance |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194337 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194314 Novel Bt toxin receptors from lepidopteran insects and methods of use |
| 08/31/2006 | US20060194311 Lna-cpg conjugates |
| 08/31/2006 | US20060194300 Process for preparing an alpha-1-antitrypsin solution |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194292 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 08/31/2006 | US20060194288 Nucleic acid molecules encoding endonucleases and methods of use thereof |
| 08/31/2006 | US20060194287 Chemokine-binding protein and methods of use |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194284 Recombinant co-expression of vitamin K epoxide reductase subunit 1 to improve vitamin K dependent protein expression |
| 08/31/2006 | US20060194283 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194282 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 08/31/2006 | US20060194281 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents |
| 08/31/2006 | US20060194279 Protein-refolding material |
| 08/31/2006 | US20060194277 Method for producing target proteins by deleting or amplifyingibpa and/or ibpb gene coding for inclusion body-associated proteins |
| 08/31/2006 | US20060194276 Specificity grafting of a murine antibody onto a human framework |
| 08/31/2006 | US20060194275 Transporter and ion channels |
| 08/31/2006 | US20060194267 Secifically a Borrelia, Babesia, or Ehrlichia; enzyme-linked immunoassay test, blot analysis, or Multi-Peptide ELISA Blot analysis of antibody levels; Lyme Disease |
| 08/31/2006 | US20060194265 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194264 Affinity based system for detecting particulates in a fluid |
| 08/31/2006 | US20060194257 MECP2E1 gene |
| 08/31/2006 | US20060194256 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 08/31/2006 | US20060194254 Method for identifying optimal binding ligands to a receptor |
| 08/31/2006 | US20060194253 A transfected cell line and a method using the same for the high throughput screening for inhibitors of the t-type calcium channel alpha-1h |
| 08/31/2006 | US20060194247 Complex of antigen, antibody or ligand, receptor; therapy or prevent human disease |
| 08/31/2006 | US20060194244 Uses of a chemokine receptor for inhibiting HIV-1 infection |
| 08/31/2006 | US20060194235 HLJ1 gene expression |
| 08/31/2006 | US20060194233 Ligand of the protein "beacon" |
| 08/31/2006 | US20060194219 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/31/2006 | US20060194210 Novel therapeutic targets in cancer |
| 08/31/2006 | US20060194204 Gene expressed in prostate cancer, methods and use thereof |
| 08/31/2006 | US20060194203 Packing cell system for eb virus vector |
| 08/31/2006 | US20060194201 Autism gene |
| 08/31/2006 | US20060194196 Novel surface protein (hbsag) variant of the hepatitis B virus |
| 08/31/2006 | US20060194195 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses |
| 08/31/2006 | US20060194194 Diagnostic measurement of disease |
| 08/31/2006 | US20060193876 Fusion proteins of Mycobacterium tuberculosis |
| 08/31/2006 | US20060193873 Functionallly reconstituted viral membranes containing adjuvant |
| 08/31/2006 | US20060193872 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 08/31/2006 | US20060193870 Compositions and methods for the therapy and diagnosis of colon cancer |
| 08/31/2006 | US20060193869 Methods and compositions for induction or promotion of immune tolerance |
| 08/31/2006 | US20060193867 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 08/31/2006 | US20060193866 H pylori antigens |
| 08/31/2006 | US20060193864 Conversion of apoptotic proteins |
| 08/31/2006 | US20060193861 Tumor necrosis factor receptors 6 alpha & 6 beta |
| 08/31/2006 | US20060193859 Methods of Treatment Using Antibodies to Neutrokine-alpha |
| 08/31/2006 | US20060193858 Full-lenth, isolated polypeptide comprising a polypeptide sequence of human SRC-like adaptor protein |
| 08/31/2006 | US20060193848 Mammalian tumor susceptibility genes and their uses |
| 08/31/2006 | US20060193847 Peptides for inhibiting retroviruses |
| 08/31/2006 | US20060193833 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 08/31/2006 | US20060193829 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/31/2006 | US20060193821 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 08/31/2006 | US20060191549 Modifying nicotine and nitrosamine levels in tobacco |
| 08/31/2006 | US20060191547 Modifying nicotine and nitrosamine levels in tobacco |
| 08/31/2006 | DE19952957B4 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 08/31/2006 | CA2642911A1 Circular permutant gfp insertion folding reporters |
| 08/31/2006 | CA2601936A1 Epidermal growth factor receptor mutations |
| 08/31/2006 | CA2601932A1 Peptides for detection of antibody to porcine reproductive respiratory syndrome virus |
| 08/31/2006 | CA2599439A1 Ykl-40 monoclonal antibody |
| 08/31/2006 | CA2598929A1 Hiv epitopes and pharmaceutical composition containing same |
| 08/31/2006 | CA2598924A1 Use of leptin for the prevention of excess body weight and composition containing leptin |
| 08/31/2006 | CA2598864A1 Promoter of regeneration of pancreatic .beta. cell, and promoter of insulin production in pancreatic .beta. cell |
| 08/31/2006 | CA2598688A1 Single branch heparin-binding growth factor analogs |
| 08/31/2006 | CA2598488A1 Immunogens from uropathogenic escherichia coli |
| 08/31/2006 | CA2598475A1 Protein and its use in diagnosing alzheimer's disease |
| 08/31/2006 | CA2571982A1 Methods of modulating intracellular degradation rates of toxins |
| 08/31/2006 | CA2569381A1 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 08/30/2006 | EP1696038A2 Isolating biological modulators from biodiverse gene fragment libraries |
| 08/30/2006 | EP1696037A2 Isolating biological modulators from biodiverse gene fragment libraries |
| 08/30/2006 | EP1696035A2 Improved bacillus host cell |
| 08/30/2006 | EP1696033A2 Pseudomonas exotoxin A-like chimeric immunogens |
| 08/30/2006 | EP1696031A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 08/30/2006 | EP1696030A1 TIE ligand homologues |
| 08/30/2006 | EP1696029A1 TIE ligand homologues |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1696027A1 Hla-dr-binding antigen peptide derived from wt1 |
| 08/30/2006 | EP1695983A2 Glucagon-like peptide-1 analogs |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |